← FDA Drug Approvals (Drugs@FDA)

CYCLOSPORINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DEVA HOLDING AS · Approved 2024-05-21

Drug application

FDA Application #

ANDA209811

Application type

Abbreviated New Drug Application (Generic)

Brand name

CYCLOSPORINE

Generic name

CYCLOSPORINE

Active ingredients

CYCLOSPORINE

Dosage form

EMULSION

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

DEVA HOLDING AS

Manufacturer

Devatis Inc.

First approval

2024-05-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown